Our mission is to improve the lives of individuals with DLG4-related Synaptopathy by supporting research, developing treatments and therapies, and providing a community of support. We understand the challenges that families face when dealing with this rare disease, and we are committed to making a difference. By collaborating with researchers, healthcare professionals, and other organizations, we aim to accelerate medical advances focused on the treatment of DLG4 Synaptopathy.
Largest programs · fiscal year 2025
2025 DLG4 SHINE Research & Family Conference$65,932 spent · 35.1% of program spending
Medical Considerations Documents sent to members who are affected by DLG4 SHINE syndrome.$624 spent · 0.3% of program spending
Research Asset Development (iPSC, Mouse, and Rat Development)$115,119 spent · 61.2% of program spending
Where each dollar went · fiscal year 2025
Of every dollar it spent, 100¢ went to programs, 0¢ to management and 0¢ to fundraising.
Programs $188,050
Management $0
Fundraising $0
In the organization's own words to the IRS, shown for context. None of this affects the America's Best Score, and a Form 990 describes programs without measuring their results.
Tax filings by year
Financial data extracted from the Form 990 the organization filed with the IRS for each fiscal year. Revenue lines can exceed 100% when other items, such as fundraising event costs, are netted against total revenue.
Revenue$379,505Fiscal year 2025
Expenses$188,050Fiscal year 2025
Total assets$0Fiscal year 2025
Total liabilities$0Fiscal year 2025
Fiscal year ending December2025
Revenue$379,505
Expenses$188,050
Net income$191,455
Net assets$0
Notable sources of revenue
Percent of total revenue
Contributions
$335,056
88.3%
Program services
$42,474
11.2%
Investment income
$1,975
0.5%
Other (net)
$0
0.0%
Assets / debt
Total assets
$0
Total liabilities
$0
Net assets
$0
Compensation
Not in our extract for this year.
Fiscal year ending December2024
Revenue$121,917
Expenses$30,041
Net income$91,876
Net assets$126,111
Notable sources of revenue
Percent of total revenue
Contributions
$122,251
100.3%
Program services
—
—
Investment income
—
—
Other (net)
−$334
−0.3%
Assets / debt
Total assets
—
Total liabilities
—
Net assets
$126,111
Compensation
Not in our extract for this year.
Fiscal year ending December2023
Revenue$84,173
Expenses$148,943
Net income−$64,770
Net assets$34,235
Notable sources of revenue
Percent of total revenue
Contributions
$5,000
5.9%
Program services
—
—
Investment income
—
—
Other (net)
$79,173
94.1%
Assets / debt
Total assets
—
Total liabilities
—
Net assets
$34,235
Compensation
Not in our extract for this year.
Fiscal year ending December2022
Revenue$107,858
Expenses$8,853
Net income$99,005
Net assets$99,005
Notable sources of revenue
Percent of total revenue
Contributions
$107,858
100.0%
Program services
$0
0.0%
Investment income
$0
0.0%
Other (net)
$0
0.0%
Assets / debt
Total assets
$99,005
Total liabilities
$0
Net assets
$99,005
Compensation
Not in our extract for this year.
About this data
Figures come from IRS Form 990 filings, through the IRS Exempt Organizations Business Master File (2026-11-09) and e-filed returns. Form 990 data typically lags 12–24 months behind an organization's fiscal year. Found an error?